KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Operating Expenses (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Operating Expenses for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 7.08% to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.5 billion through Dec 2025, up 11.18% year-over-year, with the annual reading at $9.5 billion for FY2025, 11.18% up from the prior year.
  • Operating Expenses hit $2.4 billion in Q4 2025 for Quest Diagnostics, roughly flat from $2.4 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $2.4 billion in Q3 2025 to a low of $2.0 billion in Q3 2023.
  • Historically, Operating Expenses has averaged $2.1 billion across 5 years, with a median of $2.1 billion in 2022.
  • Biggest five-year swings in Operating Expenses: skyrocketed 30.63% in 2021 and later fell 8.05% in 2023.
  • Year by year, Operating Expenses stood at $2.2 billion in 2021, then decreased by 0.45% to $2.2 billion in 2022, then fell by 8.05% to $2.0 billion in 2023, then rose by 11.83% to $2.3 billion in 2024, then rose by 7.08% to $2.4 billion in 2025.
  • Business Quant data shows Operating Expenses for DGX at $2.4 billion in Q4 2025, $2.4 billion in Q3 2025, and $2.3 billion in Q2 2025.